As someone who actually only holds australian biotech upstarts,...

As someone who actually only holds australian biotech upstarts, I reckon factor therapeutics is the one to have, not for immediate movement but once the trial recruitment is progressed my view is we will see something similar to what BOT is doing right now, and what IIL did last year (hopefully without the same trial outcome), and what PBT did the year before that (again hopefully with a different trial outcome.

Ie share price nothing much, every one bored then firecracker... just my thoughts, of course DYOR